CERo Therapeutics Holdings, Inc.
CERO
$0.8899
-$0.0579-6.11%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 671.90K | -4.23M | -2.45M | -2.30M | -1.27M |
| Total Depreciation and Amortization | 284.60K | 297.30K | 293.30K | 288.20K | 284.80K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -3.74M | 244.40K | -1.96M | -2.16M | 149.80K |
| Change in Net Operating Assets | 1.24M | 927.70K | 576.40K | -905.40K | -130.10K |
| Cash from Operations | -1.54M | -2.76M | -3.54M | -5.08M | -960.80K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -13.82M |
| Total Debt Issued | 13.70K | 0.00 | 0.00 | 408.10K | 0.00 |
| Total Debt Repaid | -102.30K | -150.90K | -149.30K | -19.70K | 41.20K |
| Issuance of Common Stock | -- | 2.57M | 2.72M | 13.70K | 1.90K |
| Repurchase of Common Stock | -500.80K | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | 2.73M | 2.00K | 6.76M | -- |
| Repurchase of Preferred Stock | -45.90K | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 2.12M | -2.66M | 13.70K | -- | -43.10K |
| Cash from Financing | 1.49M | 2.49M | 2.59M | 7.16M | 0.00 |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -53.10K | -266.80K | -946.10K | 2.08M | -960.80K |